HER2 FISH+ Rate in IHC- Gastric/Gastroesophageal Junction Adenocarcinomas

被引：0
|
作者：
Huber, A. R.
Koltz, B. R.
Hicks, D. G.
Whitney-Miller, C. L.
机构：
[1] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[2] Rochester Gen Hosp, Rochester, NY 14621 USA
来源：
LABORATORY INVESTIGATION | 2014年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
734
引用
收藏
页码：181A / 181A
页数：1
相关论文
共 50 条
  • [31] HER2 Status of Gastric or Gastroesophageal Junction Carcinomas and Corresponding Metastases by Immunohistochemistry
    Huber, A. R.
    Koltz, B. R.
    Hicks, D. G.
    Whitney-Miller, C. L.
    MODERN PATHOLOGY, 2014, 27 : 180A - 181A
  • [32] Epidemiologic study on HER2 (+) early/advanced stage gastric cancer: An evaluation on HER2 positivity in gastric and gastroesophageal junction cancers
    Erdamar, S.
    Kepil, N.
    Dursun, A.
    Ekinci, O.
    Sagol, O.
    Sarioglu, S.
    Doganavsargil, B.
    Sezak, M.
    Ozdener, F.
    Ustundag, K.
    VIRCHOWS ARCHIV, 2014, 465 : S148 - S148
  • [33] HER2/Neu Testing in 207 Gastric and Gastroesophageal Junction Adenocarcinomas: Immunohistochemistry and Silver In Situ Hybridization (SISH) Provide Effective Brightfield Methods for Clinical HER2 Testing
    Hsieh, E.
    Henry, P.
    Kwok, K.
    Hanna, W.
    LABORATORY INVESTIGATION, 2012, 92 : 163A - 163A
  • [34] HER2/Neu Testing in 207 Gastric and Gastroesophageal Junction Adenocarcinomas: Immunohistochemistry and Silver In Situ Hybridization (SISH) Provide Effective Brightfield Methods for Clinical HER2 Testing
    Hsieh, E.
    Henry, P.
    Kwok, K.
    Hanna, W.
    MODERN PATHOLOGY, 2012, 25 : 163A - 163A
  • [35] Expression of Her2/neu in gastric adenocarcinomas
    Batistatou, A.
    Lampri, E.
    Kamina, S.
    Malamou-Mitsi, V.
    VIRCHOWS ARCHIV, 2010, 457 (02) : 251 - 252
  • [36] Breast Cancer with Equivocal HER2 IHC: Does HER2 IHC Intensity Identify Areas with FISH Amplification?
    Hertel, Johann D.
    Kaiser-Rogers, Kathleen
    O'Connor, Siobhan
    Calhoun, Benjamin
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 173 - 173
  • [37] Breast Cancer with Equivocal HER2 IHC: Does HER2 IHC Intensity Identify Areas with FISH Amplification?
    Hertel, Johann D.
    Kaiser-Rogers, Kathleen
    O'Connor, Siobhan
    Calhoun, Benjamin
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 173 - 173
  • [38] Clinical significance of HER2 overexpression in gastric and gastro-esophageal junction cancers: Is there any discordance between IHC and FISH
    Baykara, M.
    Benekli, M.
    Ekinci, O.
    Irkkan, C.
    Demirci, U.
    Karaca, H.
    Unal, O. U.
    Dane, F.
    Akinci, B.
    Turkoz, F. P.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S595 - S595
  • [39] Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH
    Catenacci, Daniel V. T.
    Liao, Wei-Li
    Zhao, Lei
    Whitcomb, Emma
    Henderson, Les
    O'Day, Emily
    Xu, Peng
    Thyparambil, Sheeno
    Krizman, David
    Bengali, Kathleen
    Uzzell, Jamar
    Darfler, Marlene
    Cecchi, Fabiola
    Blackler, Adele
    Bang, Yung-Jue
    Hart, John
    Xiao, Shu-Yuan
    Lee, Sang Mee
    Burrows, Jon
    Hembrough, Todd
    GASTRIC CANCER, 2016, 19 (04) : 1066 - 1079
  • [40] Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH
    Daniel V. T. Catenacci
    Wei-Li Liao
    Lei Zhao
    Emma Whitcomb
    Les Henderson
    Emily O’Day
    Peng Xu
    Sheeno Thyparambil
    David Krizman
    Kathleen Bengali
    Jamar Uzzell
    Marlene Darfler
    Fabiola Cecchi
    Adele Blackler
    Yung-Jue Bang
    John Hart
    Shu-Yuan Xiao
    Sang Mee Lee
    Jon Burrows
    Todd Hembrough
    Gastric Cancer, 2016, 19 : 1066 - 1079
12345